BeOne Medicines (ONC) Capital Expenditures Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 227.76% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 0.57% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 143.40% |
| 10 | BeOne Medicines | - | - | 1.35 Bn | -27.93% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -27.93% |
| Dec 31, 2025 | 140.56% |
| Sep 30, 2025 | -104.39% |
| Jun 30, 2025 | -101.90% |
| Mar 31, 2025 | 103.90% |
| Dec 31, 2024 | -172.61% |
| Sep 30, 2024 | 195.85% |
| Jun 30, 2024 | -39.93% |
| Mar 31, 2024 | -54.02% |
| Dec 31, 2023 | 274.33% |
| Sep 30, 2023 | -228.34% |
| Jun 30, 2023 | 263.97% |
| Mar 31, 2023 | 41.84% |
| Dec 31, 2022 | 228.06% |
| Sep 30, 2022 | 62.07% |
| Jun 30, 2022 | 0.55% |
| Mar 31, 2022 | 46.03% |
| Dec 31, 2021 | -209.45% |
| Sep 30, 2021 | 3,313.59% |
| Jun 30, 2021 | 573.23% |
| Mar 31, 2021 | 43.53% |
| Dec 31, 2020 | 43.45% |
| Sep 30, 2020 | 129.44% |
| Jun 30, 2020 | -47.31% |
| Mar 31, 2020 | -1.35% |
| Dec 31, 2019 | 342.16% |
| Sep 30, 2019 | -117.10% |
| Jun 30, 2019 | 934.26% |
| Mar 31, 2019 | 125.12% |
| Dec 31, 2018 | 1.20% |
| Sep 30, 2018 | 110.25% |
| Jun 30, 2018 | -125.31% |
| Mar 31, 2018 | 339.93% |
| Dec 31, 2017 | -208.81% |
| Sep 30, 2017 | 319.93% |
| Jun 30, 2017 | 22.40% |
| Mar 31, 2017 | -33.27% |
| Dec 31, 2016 | 1,340.40% |
| Sep 30, 2016 | -554.69% |
| Jun 30, 2016 | 270.68% |
| Mar 31, 2016 | 2.20% |